BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34509375)

  • 1. Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years.
    Goday A; Julià H; de Vargas-Machuca A; Pedro-Botet J; Benavente S; Ramon JM; Pera M; Casajoana A; Villatoro M; Fontané L; Bisbe M; Climent E; Castañer O; Flores Le Roux JA; Benaiges D
    Surg Obes Relat Dis; 2021 Dec; 17(12):2047-2053. PubMed ID: 34509375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
    Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
    Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals.
    Pelascini E; Disse E; Pasquer A; Poncet G; Gouillat C; Robert M
    Surg Obes Relat Dis; 2016 Jan; 12(1):49-56. PubMed ID: 26164112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bariatric surgery in different obesity phenotypes: Tehran Obesity Treatment Study (TOTS).
    Barzin M; Aryannezhad S; Khalaj A; Mahdavi M; Valizadeh M; Ghareh S; Azizi F; Hosseinpanah F
    Obes Surg; 2020 Feb; 30(2):461-469. PubMed ID: 31650407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
    Haskins IN; Chang J; Nor Hanipah Z; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Obes Relat Dis; 2018 Mar; 14(3):342-346. PubMed ID: 29519663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study.
    Drai C; Chierici A; Pavone G; Benamran D; Alromayan M; Alamri A; Anty R; Liddo G; Iannelli A
    Surg Obes Relat Dis; 2024 May; 20(5):482-489. PubMed ID: 38195314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.
    Frey S; Patouraux S; Debs T; Gugenheim J; Anty R; Iannelli A
    Surg Obes Relat Dis; 2020 Dec; 16(12):2050-2057. PubMed ID: 32788075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
    Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
    Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
    Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
    Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
    Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
    Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride glucose index, pediatric NAFLD fibrosis index, and triglyceride-to-high-density lipoprotein cholesterol ratio are the most predictive markers of the metabolically unhealthy phenotype in overweight/obese adolescent boys.
    Furdela V; Pavlyshyn H; Shulhai AM; Kozak K; Furdela M
    Front Endocrinol (Lausanne); 2023; 14():1124019. PubMed ID: 37234798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery.
    Russo MF; Lembo E; Mari A; Angelini G; Verrastro O; Nanni G; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G
    J Clin Endocrinol Metab; 2021 Mar; 106(3):750-761. PubMed ID: 33248441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.